SCHEMBL23713545

SCHEMBL23713545

CCc1nc(N)cnc1C#N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 2/20 0.39
GABRD O14764 2/20 0.39
GABRA1 P14867 2/20 0.39
GABRB1 P18505 2/20 0.39
GABRG2 P18507 2/20 0.39
GABRB3 P28472 2/20 0.39
GABRA5 P31644 2/20 0.39
GABRA3 P34903 2/20 0.39
GABRA2 P47869 2/20 0.39
GABRB2 P47870 2/20 0.39
GABRA4 P48169 2/20 0.39
GABRE P78334 2/20 0.39
GABRA6 Q16445 2/20 0.39
GABRG1 Q8N1C3 2/20 0.39
GABRG3 Q99928 2/20 0.39
GABRQ Q9UN88 2/20 0.39
PIK3CD O00329 1/20 0.37
MAPK1 P28482 4/20 0.34
HSD17B10 Q99714 3/20 0.34
KDM4E B2RXH2 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12020100 0.85 ALOX5AP (0.34) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL27547103 0.79 L3MBTL1 (0.37) PIK3CDMAPK1HSD17B10KDM4EALDH1A1
SCHEMBL28750598 0.76 GABRP (0.41) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL11032347 0.76 PIK3CD (0.43) PIK3CDKDM4EALDH1A1ALOX5APFEN1
SCHEMBL23666784 0.75 HPGD (0.33) PIK3CDALOX5APFEN1
SCHEMBL15142766 0.75 PIK3CD (0.40) PIK3CDHSD17B10KDM4EALDH1A1ALOX5AP
SCHEMBL10399429 0.74 GABRP (0.40) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL23667381 0.74 MAP4K1 (0.43) PIK3CDALDH1A1ALOX5APFEN1
SCHEMBL23649687 0.74 MAP4K1 (0.43) PIK3CDALDH1A1ALOX5APFEN1
SCHEMBL23649537 0.74 MAP4K1 (0.43) PIK3CDALDH1A1ALOX5APFEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210238182-A1 IMIDAZOPYRAZINONES AS PDE1 INHIBITORS H. LUNDBECK A/S (DK) 2021-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210238182-A1 IMIDAZOPYRAZINONES AS PDE1 INHIBITORS PDE12, PDE4A, PDE5A GABRP 1368/4885GABRD 2588/4885GABRA1 1200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.